InMed Pharmaceuticals (OTCMKTS:IMLFF) Stock Price Down 5.6%

InMed Pharmaceuticals Inc (OTCMKTS:IMLFF) shares dropped 5.6% on Thursday . The company traded as low as $0.27 and last traded at $0.28, approximately 94,071 shares changed hands during mid-day trading. A decline of 75% from the average daily volume of 371,934 shares. The stock had previously closed at $0.30.

The stock’s fifty day moving average price is $0.23 and its two-hundred day moving average price is $0.31.

About InMed Pharmaceuticals (OTCMKTS:IMLFF)

InMed Pharmaceuticals Inc, a pre-clinical stage biopharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-750, a topical cannabinoid product candidate to treat epidermolysis bullosa. The company is also involved in developing INM-085, a cannabinoid-based topical therapy for glaucoma; and INM-405 for the treatment of orofacial pain.

Featured Story: Is a Roth IRA right for you?

Receive News & Ratings for InMed Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMed Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.